Role of galectin-3 as a receptor for advanced glycosylation end products
- 1 September 2000
- journal article
- review article
- Published by Elsevier BV in Kidney International
- Vol. 58, S31-S39
- https://doi.org/10.1046/j.1523-1755.2000.07706.x
Abstract
Kidney International aims to inform the renal researcher and practicing nephrologists on all aspects of renal research. Clinical and basic renal research, commentaries, The Renal Consult, Nephrology sans Frontieres, minireviews, reviews, Nephrology Images, Journal Club. Published weekly online and twice a month in print.Keywords
This publication has 70 references indexed in Scilit:
- Domain organization of Mac-2 binding protein and its oligomerization to linear and ring-like structuresJournal of Molecular Biology, 1999
- Characterization of the Advanced Glycation End-Product Receptor Complex in Human Vascular Endothelial CellsBiochemical and Biophysical Research Communications, 1999
- Regulation of Cellular Adhesion to Extracellular Matrix Proteins by Galectin-3Biochemical and Biophysical Research Communications, 1998
- Embryonic implantation in galectin 1/galectin 3 double mutant miceDevelopmental Dynamics, 1998
- Signal Transduction Pathway of Human Fibroblast Growth Factor Receptor 3Published by Elsevier BV ,1997
- Protein glycation in the kidney: Role in diabetes and agingKidney International, 1996
- Galectin-3 Is a Nuclear Matrix Protein Which Binds RNABiochemical and Biophysical Research Communications, 1995
- S-type mammalian lectins in allergic inflammationImmunology Today, 1993
- Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetesBiochemical and Biophysical Research Communications, 1990
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988